Digital TrendsExpensive gene therapy receives its first patient in a commercial treatmentDigital TrendsA patient with an extremely rare immune disease has been treated with commercial gene therapy for the first time, GlaxoSmithKline, the company behind… Continue reading
EurekAlert (press release)Role of bone marrow-derived stem cells in acute myeloid leukemia at time of diagnosisEurekAlert (press release)New Rochelle, NY, May 4, 2017-On diagnosis of acute myeloid leukemia, the mesenchymal stem cells (MSCs) in bone mar… Continue reading
Slate Magazine |
How Worried Should You Be About Mad Scientists Tinkering With Synthetic Biology at Home?
Slate Magazine This article is part of the synthetic biology installment of Futurography, a series in which Future Tense introduces readers to the technologies that will define tomorrow. Each month, we’ll choose a new technology and break it down. Future Tense is a … |
Medical News Bulletin |
Cancer Immunotherapy May Worsen Your Symptoms Depending on Your Genes
Medical News Bulletin Cancer immunotherapy is a new way to treat certain types of cancer. It works by manipulating one’s immune system to attack cancer cells, and one of the most well-known immunotherapies is to target immune checkpoints such as PDL-1 and CTLA4. When the … |
Medical News Bulletin |
Cancer Immunotherapy May Worsen Your Symptoms Depending on Your Genes
Medical News Bulletin Cancer immunotherapy is a new way to treat certain types of cancer. It works by manipulating one’s immune system to attack cancer cells, and one of the most well-known immunotherapies is to target immune checkpoints such as PDL-1 and CTLA4. When the … |
Friedreich’s Ataxia News |
Stem Cell-secreted Molecules Restore Function to Human Friedreich’s Ataxia Cells
Friedreich’s Ataxia News Stem cells, particularly those known as mesenchymal stem cells (MSCs), are being investigated extensively as potential treatments for a wide range of diseases, including neurological disorders. Their potential neuroprotective effect is linked to the … |
|
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease …
Nasdaq CARLSBAD, Calif., May 04, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that its … |
Genetic Literacy Project |
Is there hope for diabetes cure through synthetic biology?
Genetic Literacy Project More recently, though, the field of synthetic biology—a hybrid discipline that aims to construct or redesign biological components and systems—has shown the potential to produce a novel set of treatments. The solutions remain speculative, but they do … |